Olema Pharmaceuticals (OLMA) Times Interest Earned (2020)

Olema Pharmaceuticals (OLMA) has reported Times Interest Earned for 7 consecutive years, with -$0.63 the latest figure, recorded in Q1 2026.

• In Q1 2026, Times Interest Earned rose 97.61% year-over-year to -$0.63; the TTM figure through Mar 2026 stood at -$2.2 (up 97.97% YoY), while the FY2025 annual figure was -$0.76, up 95.99% from the prior year.
• Times Interest Earned climbed to -$0.63 in Q1 2026 per OLMA's latest filing, from -$165.84 in the prior quarter.
• Across five years, Times Interest Earned topped out at -$0.43 in Q3 2023 and bottomed at -$165.84 in Q4 2025.
• Historically, Times Interest Earned has averaged -$42.73 across 5 years, with a median of -$9.47 in 2022.
• Annual changes were most pronounced in 2025 — Times Interest Earned sank 17189.25% — and 2026, when it surged 97.61%.
• Olema Pharmaceuticals' Times Interest Earned stood at -$84.27 in 2022, then sank by 37.24% to -$115.65 in 2023, then decreased by 3.9% to -$120.16 in 2024, then plunged by 38.02% to -$165.84 in 2025, then jumped by 99.62% to -$0.63 in 2026.
• Business Quant data shows OLMA's Times Interest Earned at -$0.63 in Q1 2026, -$165.84 in Q4 2025, and -$147.04 in Q3 2025.